（编辑 袁冠琳） 证券日报网讯 12月4日晚间，东望时代发布公告称，新岭科技计划自公告披露之日起15个交易日后的90 天内，以集中竞价及大宗交易方式合计减持公司股份不超过10，130，335股（占公司总股本的 1.20%）。 ...

Group 1 - China Pacific Insurance has received approval from the financial regulatory authority for Wang Yuhua to serve as a director [1] - Shanghai Bank announced that the regulatory authority has approved Chen Lei's qualification as vice president [2] - Shanghai HuGong has decided to terminate the "Aerospace Equipment Manufacturing Base" fundraising project due to significant changes in project feasibility [3] Group 2 - Dongwang Times plans to reduce its stake by up to 1.20% through share sales [4] - Zhinancun intends to increase its capital by 100 million yuan in its wholly-owned subsidiary, Maigao Securities [5] - Jinxinnong reported a sales revenue of 115 million yuan from pig sales in November [6] Group 3 - Tiantan Biological has completed the Phase III clinical trial of its human prothrombin complex, showing good efficacy and safety for hemophilia B patients [7] - Beijete's subsidiary has signed a framework agreement for equity acquisition to gain control of Yunnan Wenye Nonferrous Metals [8] - Zhongsheng Pharmaceutical's RAY1225 injection has received approval for a new clinical trial indication for treating metabolic-associated fatty liver disease [9] Group 4 - Enhua Pharmaceutical's hydrochloride sulpiride tablets have passed the consistency evaluation for generic drugs [10] - Shenkong Co. plans to invest 60 million yuan in a semiconductor industry fund [11] - Lianhuan Pharmaceutical's subsidiary has received approval for its drug to pass the consistency evaluation for generic drugs [12] Group 5 - Dazhong Transportation has received approval to issue debt financing tools totaling 4.5 billion yuan [13] - Jintian Titanium Industry plans to invest 50 million yuan in an industry merger and acquisition fund [14] - Changchun Gas has committed over 1.7 billion yuan to gas facility upgrades [15] Group 6 - Laimei Pharmaceutical's innovative anti-cancer drug "Nano Carbon Iron" has received approval for clinical trials [16] - Longquan Co. has signed supply contracts worth approximately 50.76 million yuan for nuclear power components [17] - Igor plans to distribute a cash dividend of 1 yuan per 10 shares [18] Group 7 - Xingfa Group's subsidiary has signed a processing agreement for 80,000 tons of lithium iron phosphate [20] - Yunjigroup's director Wang Wanfeng has resigned for personal reasons [21] - Saiseng Pharmaceutical's application for the listing of a new drug has been accepted by the regulatory authority [22] Group 8 - Xinhua Medical has obtained registration certificates for two new medical devices [23] - Chaoying Electronics plans to invest 100 million USD in its Thai subsidiary for an AI circuit board expansion project [24] - Suzhou Planning's application to acquire 100% of Dongjin Aviation has been accepted by the Shenzhen Stock Exchange [25]

每经头条（nbdtoutiao）——让"铁疙瘩"从数万米高空精准"踩刹车"，中国商业航天"降本复用"只差"最 后一公里"！朱雀之后，同行排队接力 每经AI快讯，东望时代（SH 600052，收盘价：5.01元）12月4日晚间发布公告称，截至本公告披露日， 东科数字持有公司股份约2.24亿股（占公司总股本的26.55%）；新岭科技持有公司股份约3878万股（占 公司总股本的4.59%）。故新岭科技依然遵守关于大股东股份减持的有关规定。新岭科技计划在本公告 披露之日起15个交易日后的90天内以集中竞价及大宗交易方式，合计减持公司股份不超过约1013万股 （占公司总股本的1.2%）。 2024年1至12月份，东望时代的营业收入构成为：节能服务业占比96.67%，其他行业占比2.51%，影视 业占比0.82%。 截至发稿，东望时代市值为42亿元。 （记者 曾健辉） ...

证券代码：600052 证券简称：东望时代 公告编号：临 2025-140 浙江东望时代科技股份有限公司 关于股东减持股份的预披露公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东基本情况 2023 年，浙江东望时代科技股份有限公司（以下简称"公司"）控股股东东 阳市东科数字科技有限公司（以下简称"东科数字"）存续分立，分立为东科数 字（存续公司）和东阳市新岭科技有限公司（以下简称"新岭科技"）。东科数字 及新岭科技承诺自存续分立的相关股份过户之日（即 2023 年 6 月 26 日）起，持 续共同遵守《上市公司股东、董监高减持股份的若干规定》《上市公司董事、监 事和高级管理人员所持本公司股份及其变动管理规则》及上海证券交易所相关业 务规则中关于大股东股份减持的有关规定，包括但不限于合并计算判断大股东身 份、共用大股东的减持额度、分别履行大股东的信息披露义务等。就共用减持额 度的分配，按照东科数字与新岭科技分立时对应权益比例（即 60%：40%）计算 各自的减持额度。 截至本公告披露日，东科数 ...

Core Viewpoint - Dongwang Times (600052) announced the division of its controlling shareholder, Dongyang Dongke Digital Technology Co., Ltd. (referred to as "Dongke Digital"), into two entities: Dongke Digital (the surviving company) and Dongyang Xinling Technology Co., Ltd. (referred to as "Xinling Technology") [1] Group 1 - As of now, Dongke Digital holds 26.55% of the company's shares, while Xinling Technology holds 4.59% of the company's shares [1] - Xinling Technology plans to reduce its holdings in the company by a maximum of 10.13 million shares (accounting for 1.2% of the total share capital) within 90 days after 15 trading days through centralized bidding and block trading [1]

Group 1 - The core point of the announcement is that the shareholder, Dongyang Xinling Technology Co., Ltd., plans to reduce its stake in the company by up to 10.13 million shares, which represents 1.20% of the total share capital [1] Group 2 - The reduction will occur through centralized bidding and block trading methods [1] - The period for the share reduction is set from December 29, 2025, to March 28, 2026 [1]

Group 1 - The core point of the article is that Dongwang Times (600052.SH) announced that Newling Technology plans to reduce its shareholding in the company by up to 10.13 million shares, which accounts for 1.20% of the total share capital [1] Group 2 - The share reduction will be executed through centralized bidding and block trading methods [1] - The reduction is set to occur within 90 days after 15 trading days from the date of the announcement [1]

Group 1 - The core point of the announcement is that Dongyang New Ridge Technology Co., Ltd. plans to reduce its shareholding in the company by up to 10.130335 million shares, which represents 1.20% of the total share capital [1] - The reduction will occur through centralized bidding and block trading within 90 days after the announcement, starting 15 trading days from the date of the announcement [1] - As of the announcement date, New Ridge Technology holds 38.776639 million shares, accounting for 4.59% of the company's total share capital [1] Group 2 - The share reduction is based on the company's operational needs, and New Ridge Technology will comply with relevant laws and regulations during the process [1]

浙江东望时代科技股份有限公司 募集资金管理制度 第一章 总则 第一条 为规范浙江东望时代科技股份有限公司（以下简称"公司"）募集资 金的管理和使用，提高募集资金使用效率，最大限度地保护投资者利益，根据《中 华人民共和国公司法》《中华人民共和国证券法》《上市公司募集资金监管规则》 《上海证券交易所股票上市规则》（以下简称"《股票上市规则》"）、《上海证券交 易所上市公司自律监管指引第 1 号——规范运作》等法律法规、其他规范性文件 及《公司章程》等规定，制订本制度。 第二条 本制度所称募集资金是指公司通过发行股票或者其他具有股权性质 的证券，向投资者募集并用于特定用途的资金，但不包括公司为实施股权激励计 划募集的资金。 本制度所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 公司应当审慎使用募集资金，保证募集资金的使用与发行申请文件 的承诺相一致，不得随意改变募集资金的投向。公司董事会应当持续关注募集资 金存放、管理和使用情况，有效防范投资风险，提高募集资金使用效益。未经公 司股东会做出决议，不得改变公司募集资金用途。 第四条 公司的董事和高级管理人员应当勤勉尽责，确保公司募集资金安全， 不 ...

（2025 年 12 月修订） 第一章 总则 第一条 为建立健全浙江东望时代科技股份有限公司（以下简称"公司"）法 人治理结构，规范公司经营管理，确保总经理和其他高级管理人员依法行使职权、 履行职责、承担义务，公司依据《中华人民共和国公司法》《中华人民共和国证 券法》《上市公司治理准则》《公司章程》及相关规定，制定本细则。 第二条 本细则适用人员范围为公司总经理及其他高级管理人员，其他高级管 理人员指公司的副总经理（含常务副总经理，下同）和财务负责人。公司董事会 秘书按照公司《董事会秘书工作制度》执行，不适用本细则。 第三条 公司总经理及其他高级管理人员应当遵守法律、行政法规、《公司 章程》及本细则的规定，履行诚信和勤勉的义务。 第二章 任免资格与任免程序 浙江东望时代科技股份有限公司 总经理工作细则 （四）担任因违法被吊销营业执照、责令关闭的公司、企业的法定代表人， 并负有个人责任的，自该公司、企业被吊销营业执照、责令关闭之日起未逾三 年； （五）个人因所负数额较大债务到期未清偿被人民法院列为失信被执行人； （六）被中国证券监督管理委员会采取不得担任上市公司高级管理人员的 市场禁入措施，期限尚未届满； （七 ...